After a downward breakout on the support, the price went to the lowest lower of 1.67. However, buyers went strong and rise the price. During almost 1 month, the price was in a congestion area, and sellers try again to break the support, and they failed with strongers buyers, making a three white soldiers, and crossing the congestion area. This area was crossed...
VYNE had a favorable earnings report last week. Fundamentally, analysts predict ( linked) approximately a doubling of the shart price in the next year. Like many low share priced biotechnology stocks the price is based on perceived future earnings which can be affected by favorable FDA process, or well-received research at industry conferences and changing...
Sec.gov Inventories are stated at the lower of cost and net realizable value with cost determined on a first-in, first-out basis by product. The Company capitalizes inventory costs associated with products following regulatory approval when future commercialization is considered probable and the future economic benefit is expected to be realized. The Company...
HC Wainwright & Co. Assumes VYNE Therapeutics at Buy, Announces Price Target of $7 VYNE Therapeutics Inc., a pharmaceutical company, focuses on developing and commercializing various therapeutics for dermatology. The company offers AMZEEQ, a topical minocycline used for the treatment of inflammatory lesions of non-nodular moderate-to-severe acne vulgaris in...
Since VYNE Therapeutics has enough cash (148m) for 2021 and even into 2022 (possible to turn profitable in 2021), they have a stable cash burn rate. Indicates their financials are strong. Break-even reaches 8500 prescriptions a week / 25 million quarter. Furthermore, with two approved FDA drugs commercialized (AMZEEQ and ZILXI covered by three major PBMS,...
Is VYNE going to close this gap above on this weekly log chart ?? Good luck and happy trading!
Not a financial advice. Do your own research and have a happy trading. - the price is in decline both on h4 and daily - on H1 it starts to climb, a channel has formed that coincides with a support
VYNE Therapeutics Inc. has caught my attention recently after they announced a reverse stock split at a ratio of 1-for-4. As a novice trader, I am now interested in observing this stock's behavior as it starts trading on a split-adjusted basis, apparently on February 16th. Consequently, I have opened a position with the belief that the price will see an...
I recently discovered VYNE - Not sure how, but what made me interested in investing in this stock was their potential to help individuals with severe acne, and based on the technical aspect of bottom formed curve and "break out" from its consolidation period, I felt it was a good thought to get into this company. It might actually become my future pension fund....
VYNE gapped strongly on 25th January, breaking out of a 10-month resistence @ 2.68 but alas failed to hold on to this level as it then gave up all the gains over the next 1 week to close the gap before attempting to reverse up again. It finally broke and CLOSED above this 2.68 resistence (now turned support) on 3rd Feb, retesting this new support over the next...
Crossing any of the green lines will give us an understanding of where the price action will take us.